Bio-plastics production grows to 7.5 million tonnes
The market for bio-based building blocks and polymers showed moderate growth to 7.5 million tonnes in 2018 and will grow with a CGAR of 4% by 2023 reports German nova-Institute.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1118 entries already.
Entries by Thomas Gabrielczyk
Reprogrammed pancreatic cells cure type I diabetes
/in News/by Thomas GabrielczykSwiss researchers have demonstrated a way to cure type I diabetes without cell transplantation. In model mice the reprogrammed non-islet cells from human pancreas
Industrial biotech hub validates start-up ideas
/in News/by Thomas GabrielczykBiotech Campus Delft, Royal DSM and YES!Delft partner up have launched a Biotech Validation Lab to validate the business concepts of European biotech startups.
uniqure delivers POC for hemophilia B gene therapy
/in News/by Thomas GabrielczykGene therapy uniQure NV (Amsterdam) reported that factor IX levels of patients with severe hemophilia B raised to a mean of 38% of normal 12 weeks after a single injection of AMT-061.
Ose Pharma gets clinical milestone for IL7R antagonist
/in News/by Thomas GabrielczykOse Immunotherapeutics has got the first milestone payment within its 272m deal with Servier inked in 2016.
How stroma cells trigger tumour angiogenesis
/in News/by Thomas GabrielczykAnalyses of the stroma cell proteome have revealed how intratumoral hypoxia triggers the formation of dysfunctional blood vessels that block drugs from entering the tumour and push metastasis.
Jennewein Biotechnologie expands into Chinese market
/in News/by Thomas GabrielczykJennewein Biotechnologie and Asia’s largest dairy company Yili Group have joined forces to develop an innovative infant formula tailored to the Chinese market.
Medicxi put 40m into two Sosei spin off companies
/in News/by Thomas GabrielczykSosei Group Corporation has spun out two programmes of its neurology pipeline into two newly created companies funded by venture fund Medicxi.
EMA greenlights two orphan drugs and two biosimilars
/in News/by Thomas GabrielczykEMAs human medicines committee (CHMP) recommended six medicines for approval at its January 2019 meeting.
Hitachi expands European reach in cell and gene therapy
/in News/by Thomas GabrielczykHitachi Chemical Co. Ltd. is set to takeover cell and gene therapy CDMO apceth Biopharma GmbH to get a foothold in Europe, the second largest market for advanced therapies after the […]